THE NEW HOPE FOR PHYSIQUE MANAGEMENT ?

Experts are increasingly focused on retatrutide, a novel drug from Eli Lilly, as a significant advance in weight management. Unlike many earlier approaches, retatrutide is a twin-action agonist targeting both GLP-1 and GIP, hormones that affect hunger and glucose regulation . Preliminary patient